Watching obesity in people using XOWI
Part of Hormones & metabolism clinical trials.
This study observes how obesity changes during the use of a treatment called XOWI. It may help researchers understand whether it’s safe and potentially helpful for people with higher body weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 16 and 70 years old
- Your body mass index (BMI) must be over 28
- Your obesity should not be caused by another medical condition (like Cushing syndrome or hormone problems)
- You cannot be pregnant or breastfeeding
- You should not have serious heart, liver, kidney, or other major organ problems
- Your blood pressure should be below 180/110 and you should not have malignant (dangerous) hypertension
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called XW003 to see if it helps people with obesity and obstructive sleep apnea who are already using a positive airway pressure (PAP) machine, like CPAP. It aims to improve weight loss and sleep apnea symptoms.
This trial tests an investigational weekly injection called XW003 for weight loss in people who have obesity and moderate-to-severe sleep apnea but do not use a CPAP machine. It aims to see if the drug can help with weight loss and improve sleep apnea without the need for a breathing machine.
This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This study tests an investigational medication, orforglipron, taken as a pill to help people with excess weight lose weight. It may be an option for people who have not been able to lose weight with diet alone and who also have weight-related health problems.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.